These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 16630609)
1. Modulation of human TRPV1 receptor activity by extracellular protons and host cell expression system. Bianchi BR; Lee CH; Jarvis MF; El Kouhen R; Moreland RB; Faltynek CR; Puttfarcken PS Eur J Pharmacol; 2006 May; 537(1-3):20-30. PubMed ID: 16630609 [TBL] [Abstract][Full Text] [Related]
2. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo. Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644 [TBL] [Abstract][Full Text] [Related]
3. Molecular cloning, functional characterization of the porcine transient receptor potential V1 (pTRPV1) and pharmacological comparison with endogenous pTRPV1. Ohta T; Komatsu R; Imagawa T; Otsuguro K; Ito S Biochem Pharmacol; 2005 Dec; 71(1-2):173-87. PubMed ID: 16288992 [TBL] [Abstract][Full Text] [Related]
4. TRPV1b overexpression negatively regulates TRPV1 responsiveness to capsaicin, heat and low pH in HEK293 cells. Vos MH; Neelands TR; McDonald HA; Choi W; Kroeger PE; Puttfarcken PS; Faltynek CR; Moreland RB; Han P J Neurochem; 2006 Nov; 99(4):1088-102. PubMed ID: 17018028 [TBL] [Abstract][Full Text] [Related]
5. A polyclonal antibody to the prepore loop of transient receptor potential vanilloid type 1 blocks channel activation. Klionsky L; Tamir R; Holzinger B; Bi X; Talvenheimo J; Kim H; Martin F; Louis JC; Treanor JJ; Gavva NR J Pharmacol Exp Ther; 2006 Oct; 319(1):192-8. PubMed ID: 16844842 [TBL] [Abstract][Full Text] [Related]
6. Role of TRPV1 receptors in descending modulation of pain. Palazzo E; Rossi F; Maione S Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S79-83. PubMed ID: 18325659 [TBL] [Abstract][Full Text] [Related]
7. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor. Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405 [TBL] [Abstract][Full Text] [Related]
8. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480 [TBL] [Abstract][Full Text] [Related]
9. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid. El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819 [TBL] [Abstract][Full Text] [Related]
10. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line. Szoke E; Börzsei R; Tóth DM; Lengl O; Helyes Z; Sándor Z; Szolcsányi J Eur J Pharmacol; 2010 Feb; 628(1-3):67-74. PubMed ID: 19958765 [TBL] [Abstract][Full Text] [Related]
11. Cloning and pharmacological characterization of mouse TRPV1. Correll CC; Phelps PT; Anthes JC; Umland S; Greenfeder S Neurosci Lett; 2004 Nov; 370(1):55-60. PubMed ID: 15489017 [TBL] [Abstract][Full Text] [Related]
12. Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord. Bianchi BR; El Kouhen R; Chen J; Puttfarcken PS Eur J Pharmacol; 2010 May; 633(1-3):15-23. PubMed ID: 20153316 [TBL] [Abstract][Full Text] [Related]
13. The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection. Peng J; Li YJ Eur J Pharmacol; 2010 Feb; 627(1-3):1-7. PubMed ID: 19879868 [TBL] [Abstract][Full Text] [Related]
14. A novel role for the TRPV1 channel in UV-induced matrix metalloproteinase (MMP)-1 expression in HaCaT cells. Lee YM; Kim YK; Kim KH; Park SJ; Kim SJ; Chung JH J Cell Physiol; 2009 Jun; 219(3):766-75. PubMed ID: 19206161 [TBL] [Abstract][Full Text] [Related]
15. Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine. Sadofsky LR; Campi B; Trevisani M; Compton SJ; Morice AH Exp Lung Res; 2008 Dec; 34(10):681-93. PubMed ID: 19085565 [TBL] [Abstract][Full Text] [Related]
17. Role of endocannabinoids and endovanilloids in Ca2+ signalling. De Petrocellis L; Di Marzo V Cell Calcium; 2009 Jun; 45(6):611-24. PubMed ID: 19356798 [TBL] [Abstract][Full Text] [Related]
18. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603 [TBL] [Abstract][Full Text] [Related]
19. Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). Woo DH; Jung SJ; Zhu MH; Park CK; Kim YH; Oh SB; Lee CJ Mol Pain; 2008 Oct; 4():42. PubMed ID: 18826653 [TBL] [Abstract][Full Text] [Related]
20. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1. Gavva NR; Tamir R; Klionsky L; Norman MH; Louis JC; Wild KD; Treanor JJ Mol Pharmacol; 2005 Dec; 68(6):1524-33. PubMed ID: 16135784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]